Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) utilizes the angiotensin‐converting enzyme‐2 (ACE‐2) receptor to enter human cells. Angiotensin‐converting enzyme inhibitors (ACEI) and angiotensin II receptor antagonists (ARB) are associated with ACE‐2 upregulation. We hypoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Palazzuoli, Alberto, Mancone, Massimo, De Ferrari, Gaetano M., Forleo, Giovanni, Secco, Gioel G., Ruocco, Gaetano M., D'Ascenzo, Fabrizio, Monticone, Silvia, Paggi, Anita, Vicenzi, Marco, Palazzo, Anna G., Landolina, Maurizio, Taravelli, Erika, Tavazzi, Guido, Blasi, Francesco, Infusino, Fabio, Fedele, Francesco, De Rosa, Francesco G., Emmett, Michael, Schussler, Jeffrey M., Tecson, Kristen M., McCullough, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763715/
https://www.ncbi.nlm.nih.gov/pubmed/33023356
http://dx.doi.org/10.1161/JAHA.120.017364

Ejemplares similares

Ejemplares similares